CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil

Management will discuss the data from the recently completed Phase 3 trial for severe-to-critically ill COVID-19 patients, the regulatory path forward with several countries, as well as updates on other clinical and corporate priorities.